Commenters on the US Food and Drug Administration’s (FDA) draft guidance outlining principles for in vivo or in vitro bioequivalence studies (BE) for investigational new drugs (INDs), new drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results